» Articles » PMID: 12692054

Progressive Sclerosing Cholangitis After Septic Shock: a New Variant of Vanishing Bile Duct Disorders

Overview
Journal Gut
Specialty Gastroenterology
Date 2003 Apr 15
PMID 12692054
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We present nine patients with progressive sclerosing cholangitis after septic shock.

Patients: All nine patients had previously required long term treatment in an intensive care unit for septic shock: two patients with polytrauma, five with burn injury, and two with extensive surgery. They were admitted to our hospital because of cholangitis. Endoscopic retrograde cholangiography revealed severe intrahepatic stenoses in all patients and liver biopsies showed typical signs of sclerosing cholangitis. No patient had pre-existing liver disease.

Results: Mean follow up time was 35 months. In patients with major bile duct stenoses (3/9), 12 endoscopic dilations were performed in total. In one patient, concrements were extracted and intermittent stenting was necessary. To date, 4/9 patients have rapidly developed liver cirrhosis. During follow up, 5/9 patients died: two after fulminant cholangitis, one after liver failure, one due to liver transplantation associated problems, and one after cerebral ischaemia. One patient has been registered for transplantation and the remaining three patients show no acute signs of liver failure.

Conclusions: Patients with sclerosing cholangitis, following septic shock, represent a new variant of vanishing bile duct disorders. In such patients liver disease rapidly progresses to cirrhosis. Endoscopic treatment may only transiently improve the course of the disease. Orthotopic liver transplantation is indicated in end stage disease.

Citing Articles

Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?.

John N, Ibrahim B, Ebaid M, Saab S Hepat Med. 2023; 15:185-193.

PMID: 37850074 PMC: 10578169. DOI: 10.2147/HMER.S371507.


Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?.

Bartoli A, Cursaro C, Seferi H, Andreone P Hepat Med. 2023; 15:93-112.

PMID: 37547355 PMC: 10404108. DOI: 10.2147/HMER.S384220.


BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.

Stahl K, Klein F, Voigtlander T, Grosshennig A, Book T, Muller T Trials. 2023; 24(1):247.

PMID: 37004078 PMC: 10067228. DOI: 10.1186/s13063-023-07260-w.


Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.

Bauer U, Pavlova D, Abbassi R, Lahmer T, Geisler F, Schmid R Clin J Gastroenterol. 2022; 15(6):1124-1129.

PMID: 35953614 PMC: 9371366. DOI: 10.1007/s12328-022-01687-5.


Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis.

Gadour E, Hassan Z Prz Gastroenterol. 2022; 17(1):1-8.

PMID: 35371357 PMC: 8942010. DOI: 10.5114/pg.2021.110483.


References
1.
Loinaz C, Gonzalez E, Jimenez C, Garcia I, Gomez R, Gonzalez-Pinto I . Long-term biliary complications after liver surgery leading to liver transplantation. World J Surg. 2001; 25(10):1260-3. DOI: 10.1007/s00268-001-0106-4. View

2.
Pitt H, King 3rd W, Mann L, Roslyn J, Berquist W, Ament M . Increased risk of cholelithiasis with prolonged total parenteral nutrition. Am J Surg. 1983; 145(1):106-12. DOI: 10.1016/0002-9610(83)90175-7. View

3.
Moore F, Moore E . Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995; 75(2):257-77. DOI: 10.1016/s0039-6109(16)46587-4. View

4.
Messing B, Bories C, Kunstlinger F, BERNIER J . Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?. Gastroenterology. 1983; 84(5 Pt 1):1012-9. View

5.
HOLZBACH R . Gallbladder stasis: consequence of long-term parenteral hyperalimentation and risk factor for cholelithiasis. Gastroenterology. 1983; 84(5 Pt 1):1055-8. View